Jennifer Crombie, Md
Clinical trials sponsored by Jennifer Crombie, Md, explained in plain language.
-
New combo therapy offers hope for rare blood cancer
Disease control Recruiting nowThis study tests whether adding the drug pembrolizumab to standard CAR-T cell therapy can improve outcomes for people with a rare type of lymphoma (PMBCL) that has come back or not responded to prior treatment. About 35 adults will receive the combination and be monitored for 6 m…
Phase: PHASE2 • Sponsor: Jennifer Crombie, MD • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for aggressive lymphoma: triple therapy shows promise in early trial
Disease control Recruiting nowThis study tests whether adding two targeted drugs, glofitamab and polatuzumab, to standard chemotherapy (R-CHP) can improve outcomes for people with high-risk diffuse large B-cell lymphoma. About 41 adults with untreated disease will receive the combination. The main goal is to …
Phase: PHASE2 • Sponsor: Jennifer Crombie, MD • Aim: Disease control
Last updated May 08, 2026 12:01 UTC